Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: Results from five prospective cohort studies

References

• Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253–63.
   PubMed Web of Science ®Google Scholar
• Kuehl FA Jr, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science. 1980;210:978–84.
   PubMed Web of Science ®Google Scholar
• Klegeris A, McGeer PL. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging. 2002;23:787–94.
   PubMed Web of Science ®Google Scholar
• Carty ML, Wixey JA, Reinebrant HE, Gobe G, Colditz PB, Buller KM. Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia-ischemia in the immature rodent brain. Brain Res. 2011;1402: 9–19.
   PubMed Web of Science ®Google Scholar
• Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, . Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol. 2002;52:771–8.
   PubMed Web of Science ®Google Scholar
• Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2003;17:725–7.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, . Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol. 2006;60: 22–31.
   PubMed Web of Science ®Google Scholar
• Popat RA, Tanner CM, van den Eeden SK, Bernstein AL, Bloch DA, Leimpeter A, . Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:157–63.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, . Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338:464–8.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Manson JE, Hankinson SE. The Nurses’ Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49–62.
   PubMed Web of Science ®Google Scholar
• Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, . The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer. 2002;94:2490–501.
   PubMed Web of Science ®Google Scholar
• Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, . A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151:346–57.
   PubMed Web of Science ®Google Scholar
• Leitzmann MF, Park Y, Blair A, Ballard-Barbash R, Mouw T, Hollenbeck AR, . Physical activity recommendations and decreased risk of mortality. Arch Intern Med. 2007;167:2453–60.
   PubMed Web of Science ®Google Scholar
• Wang H, O'Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, . Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of five prospective cohorts. Arch Neurol. 2011;68:207–13.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, McCullough ML, Calle EE, Thun MJ, Cudkowicz M, Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. 2004;160:26–33.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Gao X, Chen H, Schwarzschild MA, Ascherio A. Use of ibuprofen and risk of Parkinson's disease. Neurology. 2011;76:863–9.
   PubMed Web of Science ®Google Scholar
• Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, . A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA. 1991;266:521–7.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Lifetime non-narcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004; 164:1519–24.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
   Google Scholar
• Wang H, O’Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Schatzkin A, . Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from five prospective cohort studies. Am J Epidemiol. 2011; 173:595–602.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, . Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003; 22:217–28.
   PubMed Web of Science ®Google Scholar
• Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis. 1971;24:5–8.
   PubMedGoogle Scholar
• Chio A. Risk factors in the early diagnosis of ALS: European epidemiological studies. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(Suppl 1):S13–8.
   PubMedGoogle Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Cho E, Curhan G, Hankinson SE, Kantoff P, Atkins MB, Stampfer M, . Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med. 2011; 171:1487–93.
   PubMedGoogle Scholar
• Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med. 2007;167:394–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Canosa A, Gallo S, Moglia C, Ilardi A, Cammarosano S, . Pain in amyotrophic lateral sclerosis: a population based controlled study. Eur J Neurol.2011; 19:551–5.
   Google Scholar
• Cellura E, Spataro R, Taiello AC, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2011;114:550–4.
   PubMedGoogle Scholar
• Kano O, Beers DR, Henkel JS, Appel SH. Peripheral nerve inflammation in ALS mice: cause or consequence. Neurology. 2012;78:833–5.
   PubMed Web of Science ®Google Scholar
• Moisse K, Strong MJ. Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762:1083–93.
   PubMed Web of Science ®Google Scholar
• Schwartz M, Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol. 2010;6: 405–10.
   PubMedGoogle Scholar
• McCombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011; 11:246–54.
   PubMed Web of Science ®Google Scholar
• Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem. 2004;88:576–82.
   PubMed Web of Science ®Google Scholar
• Qureshi M, Shui A, Dibernardo AB, Brown RH Jr, Schoenfeld DA, Cudkowicz ME. Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:369–74.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, . Non-steroidal anti-inflammatory drugs and the risk of Parkinson's disease. Arch Neurol. 2003;60:1059–64.
   PubMed Web of Science ®Google Scholar
• Pasqualetti P, Bonomini C, Dal Forno G, Paulon L, Sinforiani E, Marra C, . A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease. Aging Clin Exp Res. 2009;21:102–10.
   PubMed Web of Science ®Google Scholar
• McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, . Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Res. 2008;1207:225–36.
   PubMed Web of Science ®Google Scholar